As cannabis legalization expands across the United States, more cancer patients are turning to the drug for relief from pain, nausea, anxiety, and other treatment-related symptoms. However, the medical community appears to be lagging behind in its ability to offer informed guidance. According to the survey, a majority of oncologists admitted they lacked adequate knowledge or formal training in cannabis therapeutics. Only a minority reported feeling confident in advising patients on cannabis use, dosing, or potential drug interactions.
This knowledge gap is particularly striking given the sharp rise in patients proactively seeking information or requesting medical cannabis as part of their care. Many oncologists reported that their patients were often more familiar with cannabis products than they were, leading to a reversal of the typical doctor-patient dynamic. In some cases, physicians found themselves learning from patients or relying on anecdotal evidence rather than clinical data.
One of the primary barriers to medical cannabis education is the limited integration of cannabis science into medical school curricula and continuing education programs. While some states have enacted their own medical cannabis training standards for healthcare professionals, there is no consistent national framework to ensure oncologists are equipped with the necessary knowledge.
The lack of rigorous, standardized research has also contributed to the uncertainty. Due to federal restrictions, comprehensive clinical studies on cannabis remain limited, leaving many questions unanswered about safety, efficacy, and best practices in oncology care. This has led to a situation where even physicians open to cannabis-based interventions are hesitant to recommend them without stronger scientific backing.
Experts argue that as cannabis becomes an increasingly common part of cancer care conversations, the medical community must adapt. This includes creating more opportunities for clinicians to receive evidence-based education and updating professional guidelines to reflect evolving patient needs and public policy.
Until then, a disconnect will likely remain—between what cancer patients are asking for and what their doctors feel prepared to provide. Bridging that gap is now a pressing challenge for both medical educators and healthcare institutions.
Dabbin-Dad Newsroom
If you liked this post, say thanks by sharing it
